Founder Jailed After 37 Million Pills

Person holding a prescription bottle and reading medical instructions

Federal prosecutors say a flashy telehealth startup quietly turned millions of Adderall pills into a nationwide “pill mill,” and its founder is now headed to prison.

Story Snapshot

Done Global founder Ruthia He was sentenced to six years in federal prison and fined $1 million for a massive Adderall distribution and fraud scheme.
Prosecutors say the company’s platform helped unlawfully distribute more than 37 million Adderall pills and cheat insurers out of over $12 million.
Clinicians allegedly prescribed stimulants at 30‑second intervals, sometimes to patients they never evaluated and even to people who were hospitalized or dead.
The case is part of a wider federal crackdown on telehealth “pill mills” that grew after COVID‑era rule changes made online prescribing easier.

Telehealth CEO Sentenced for Massive Adderall Scheme

Federal court in California has sentenced Done Global founder and former chief executive officer Ruthia He to six years in prison and a $1 million fine. The Department of Justice said she used the company’s technology platform, pay model, and clinical rules to unlawfully move more than 37 million pills of Adderall, a controlled stimulant often used to treat attention deficit hyperactivity disorder. Prosecutors also say the scheme cheated Medicare, Medicaid, and private insurers out of more than $12 million through false claims.

A federal jury had already convicted He in November 2025 on serious drug and fraud charges. Jurors found her guilty of conspiracy to distribute controlled substances, multiple counts of illegal distribution, and conspiracy to commit health care fraud. She was also convicted of conspiring to obstruct justice after authorities said she tried to interfere with the investigation. The Justice Department calls this case one of its first criminal drug distribution prosecutions against a digital health company that used telemedicine to push controlled substances.

Assembly‑Line Prescribing and Aggressive Marketing

Evidence described by the Department of Justice and reported by major outlets shows just how fast the company was pushing pills. Clinicians working with Done Global issued Adderall prescriptions at intervals as short as 30 seconds, a pace that leaves little room for real medical judgment. Executives reportedly pressured these prescribers to approve stimulants even when they believed a patient did not have attention deficit hyperactivity disorder, and kept refilling Adderall automatically, including for people who were in locked psychiatric wards or had already died.

Clinical president David Brody played a central role and was sentenced separately to two years in prison and a $1 million fine. Reporting based on court records says Brody personally prescribed 394,324 stimulant pills to patients he never evaluated himself, relying on the company’s automated systems and brief online forms instead of full exams. Prosecutors say this high‑speed, high‑volume model was not an accident but a business strategy meant to boost subscription revenue and make the company more valuable to investors, even as it increased addiction and overdose risks for patients.

From Tech Darling to Cautionary Tale

Done Global was founded in 2019 by He, a former product designer at large tech firms, with no medical training of her own. The company promised easy online access to attention deficit hyperactivity disorder care through quick virtual visits and home delivery of medication. During the COVID‑19 pandemic, when regulators relaxed rules on remote prescribing of controlled drugs, Done’s model grew rapidly as people stuck at home looked for help with focus, stress, and anxiety. Federal investigators now say those same flexibilities were exploited to run what they describe as a nationwide pill mill wrapped in sleek tech branding.

Government statements say Done Global and its leaders used aggressive and sometimes deceptive online advertising to feed the scheme. Ads targeted Americans who were struggling with aging, remote work, or general stress and told them these common problems meant they had attention deficit hyperactivity disorder, with Adderall pitched as the fix. According to the Internal Revenue Service’s Criminal Investigation unit, He and Done spent more than $40 million on social media ad campaigns meant to pull in new customers and drive more stimulant prescriptions through the platform.

A Warning Shot in the Telehealth Crackdown

This case lands in the middle of a larger federal push against fraud in telehealth that began after emergency COVID‑era changes made virtual care easier. Reports from health policy groups and government watchdogs describe a small but troubling share of telehealth providers billing at very high volumes, sometimes for services that appear medically unnecessary. These patterns include large numbers of brief online visits, little or no real patient contact, and heavy use of expensive drugs or tests — all red flags that regulators say can point to abuse.

Psychiatrist David Brody gets two years prison for Adderall distribution scheme

Former Done Global Clinical President Dr. David Brody has been sentenced to two years in federal prison and fined $1 million for his role in a multimillion-dollar telehealth scheme that illegally…

— PsychCrime (@psychcrime) July 9, 2026

For many Americans across the political spectrum, the Done Global case taps into a deeper worry that powerful people used a public health crisis to get rich while ordinary patients and taxpayers carried the risk. Supporters of stricter enforcement see the sentences as proof that at least some “telehealth pill mills” are finally being held to account. Others note that most telehealth providers follow the rules, and warn that heavy‑handed crackdowns could also hurt patients who depend on legal, well‑run virtual care.